Delivery Order SPE2DB22D2206-SPE2DB24FGS70

Award Date 4/17/24
Potential Completion Date 5/8/24
Potential Value $12K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has an award value of $26,849.76 and is a Firm Fixed Price Delivery Order for the supply of GAMUNEX-C 20 GRAM/200 ML VIAL 200ML. The contract has an ultimate completion date of February 6, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $34,908.00, is for the delivery of GAMUNEX-C 40 GRAM/400 ML VIAL 400ML medical product. The award is a Firm Fixed Price Delivery Order with a performance period through February 5, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the delivery of GAMUNEX-C 20 GRAM/200 ML VIAL 200ML, a pharmaceutical product, with a ceiling value of $35,404.20. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 7, 2025. The contract is not designated with any set-aside requirements,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GAMUNEX-C 20 gram/200 ml vials, a pharmaceutical product, with a ceiling value of $11,801.40. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of GAMUNEX-C 40 gram/400 ml vial pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The firm fixed price delivery order has a ceiling value of $14,427.24 and a performance period through April 25, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31,...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, with a ceiling value of $2,226.73, is for the delivery of GAMUNEX-C 10 gram/100 ml vials. It is a firm-fixed price delivery order contract with an ultimate completion date of March 26, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, worth $20,942.80, is for the delivery of GAMUNEX-C 20 gram/200 mL vials. This is a firm fixed-price delivery order contract with an ultimate completion date of February 5, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the supply of a pharmaceutical product, GAMUNEX-C 40 GRAM/400 ML VIAL 400ML, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $9,618.16 and a completion date of June 4, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves as...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product GAMUNEX-C 20 GRAM/200 ML VIAL 200ML. The contract, which does not have a set-aside designation, was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a ceiling value of $14,295.00. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is July 8, 2024. Amerisourcebergen Drug Corp is a major...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product GAMUNEX-C 5 GRAM/50 ML VIAL 50ML. The contract has a ceiling value of $5,918.60 and is a Firm Fixed Price Delivery Order placed by the Defense Logistics Agency (DLA), a defense agency. The award has no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FGS70
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) for the delivery of the pharmaceutical product GAMUNEX-C 20 GRAM/200 ML VIAL 200ML. The contract has a ceiling value of $11,912.50 and a performance period ending on May 8, 2024.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The current award appears to be a specific delivery order issued under this IDC. The contract does not have a set-aside designation.

Generated 7/17/24, 9:17 AM